CD8A and neoplasm: Recent foundational research has discovered that directly supplementing glutamine in tumor tissues can enhance CD8+ T cell-mediated antitumor immunity and overcome resistance to checkpoint blockade and T cell-mediated immunotherapies (30, 31).